Buscar en
Allergologia et Immunopathologia
Toda la web
Inicio Allergologia et Immunopathologia The predictive factors for remission of chronic spontaneous urticaria in childho...
Journal Information
Vol. 44. Issue 6.
Pages 537-541 (November - December 2016)
Download PDF
More article options
Vol. 44. Issue 6.
Pages 537-541 (November - December 2016)
Original Article
DOI: 10.1016/j.aller.2016.04.011
The predictive factors for remission of chronic spontaneous urticaria in childhood: Outcome from a prospective study
I. Esera,
Corresponding author

Corresponding author.
, N. Yologlua, C. Baydemirb, M. Aydogana
a Division of Pediatric Allergy and Immunology, Kocaeli University, 41380 Umuttepe, Kocaeli, Turkey
b Department of Biostatistics and Medical Informatics, Kocaeli University, Kocaeli, Turkey
Article information
Full Text
Download PDF
Figures (1)
Tables (2)
Table 1. Demographic and clinical features of the patients.
Table 2. The clinical and laboratory profiles of the remission and non-remission groups at three years (at the end of study).
Show moreShow less

There are few studies in children on the natural course of chronic spontaneous urticaria (CSU) because of its relative infrequency in childhood.


To estimate the rate of remission and evaluate the prognostic factors in children with CSU.


A total of 52 children with CSU were prospectively followed over a period of three years.


The remission rates at 12 months and 36 months were 32.7% and 48.1%. The mean duration of disease at the first visit in the non-remission group was higher than in the remission group at the end of the study (P=0.016). The remission rate of the patients who had been treated by standard dose antihistamine was higher than that of the patients who had been treated with the high-dose antihistamine and combination medications (P=0.004, P<0.001). The treatment steps were independent prognostic factors for remission by logistic regression analysis.


Our study indicates that urticaria controlled by a standard dose of antihistamine can predict a good prognosis independently from disease duration at first visit.

Chronic urticaria
Predictive factors


These are the options to access the full texts of the publication Allergologia et Immunopathologia

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe to

Allergologia et Immunopathologia

Comprar acceso al artículo

Comprando el artículo el PDF del mismo podrá ser descargado

Precio 22,50 €

Comprar ahora
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.